Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018200393) PHARMACEUTICAL COMPOSITION FOR IN VIVO DELIVERY, METHOD OF PREPARATION OF A SUBSTANTIALLY WATERINSOLUBLE PHARMACOLOGICALLY ACTIVE AGENT
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/200393 International Application No.: PCT/US2018/028900
Publication Date: 01.11.2018 International Filing Date: 23.04.2018
IPC:
A61K 31/00 (2006.01) ,A61K 31/337 (2006.01) ,A61K 47/18 (2017.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
337
having four-membered rings, e.g. taxol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
06
Organic compounds
16
containing nitrogen
18
Amines; Quaternary ammonium compounds
Applicants:
ZY THERAPEUTICS INC. [US/US]; 12218 Bradford Green Square, Suite 220 Cary, NC 27519, US
Inventors:
LI, Jun; US
BAO, Jian; US
RONE, Aili; US
Agent:
CHEN, Shengfeng; US
Priority Data:
62/489,19824.04.2017US
Title (EN) PHARMACEUTICAL COMPOSITION FOR IN VIVO DELIVERY, METHOD OF PREPARATION OF A SUBSTANTIALLY WATERINSOLUBLE PHARMACOLOGICALLY ACTIVE AGENT
(FR) COMPOSITION PHARMACEUTIQUE POUR L'ADMINISTRATION IN VIVO, PROCÉDÉ DE PRÉPARATION D'UN PRINCIPE PHARMACOLOGIQUEMENT ACTIF SENSIBLEMENT INSOLUBLE DANS L'EAU
Abstract:
(EN) The present application discloses a pharmaceutical composition for in vivo delivery. The pharmaceutical composition includes a pharmacologically active agent and a pharmaceutically acceptable carrier. The pharmaceutically acceptable carrier includes a biocompatible polymer. The biocompatible polymer and the pharmacologically active agent are formulated as particles. The pharmaceutical composition is free of a water-immiscible solvent.
(FR) La présente demande concerne une composition pharmaceutique pour l'administration in vivo qui comprend un principe pharmacologiquement actif et un véhicule pharmaceutiquement acceptable. Le véhicule pharmaceutiquement acceptable comprend un polymère biocompatible. Le polymère biocompatible et le principe pharmacologiquement actif sont formulés sous forme de particules. La composition pharmaceutique est exempte de solvant non miscible à l'eau.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)